Mikkael A. Sekeres, MD

Leukemia/Myeloma, AML, CHIP, CML, MDS

His research focuses on patients with myelodysplastic syndromes (MDS) and older adults with acute myeloid leukemia (AML).

View Publications.

Dr. Mikkael A. Sekeres joined the University of Miami Health System and Sylvester Comprehensive Cancer Center as Chief of the Division of Hematology. He earned his medical degree and a Master’s Degree in clinical epidemiology from the University of Pennsylvania School of Medicine. Dr. Sekeres completed his postgraduate training at Harvard University, finishing an internal medicine residency at Massachusetts General Hospital and a fellowship in hematology-oncology at the Dana Farber Cancer Institute in Boston. He chaired the Oncology Drugs Advisory Committee of the FDA, has been on the editorial boards for several medical journals, and chairs scientific advisory boards for patient advocacy groups and research funding agencies. He will practice out of Sylvester Comprehensive Cancer Center with a focus on Leukemia and Myeloid Disorders.
Dr. Sekeres' career highlights include:
●His research focuses on patients with myelodysplastic syndromes (MDS) and older adults with acute myeloid leukemia (AML)
● He has been the national and international primary study investigator on dozens of phase I/II/III clinical trials
● He is the author or co-author of over 400 manuscripts and 600 meeting abstracts
● He is a frequent essayist for The New York Times and has written 8 books
● He is on the Executive Committee of the American Society of Hematology and a member of the American Society of Clinical Oncology and the Southwest Oncology Group —Leukemia Committee